WINNIPEG, MANITOBA -- (MARKET WIRE) -- May 03, 2007 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced it is providing an educational grant to support an accredited satellite symposium during The American Association for Thoracic Surgery’s 87th Annual Meeting in Washington, D.C. The symposium will highlight Medicure’s lead clinical product MC-1’s potential role in the treatment of coronary artery bypass graft (CABG) surgery patients.
